生命科学资讯

How Merck plans to set a buffer for Keytruda's patent cliff

AirNexis takes flight with $200M, links up with China pharma for COPD asset in $955M biobucks deal

Orca rides $250M funding wave toward cancer cell therapy launch

3 new venture funds collect nearly $1B for biotech in US, EU

Once employing 550, Thermo Fisher will leave Asheville, company says - The Asheville Citizen Times

Thermo Fisher to end operations at Weaverville site - 828 News Now

Aktis' 25% IPO bounce builds hope for 2026's public offerings

10X Genomics stock hits 52-week high at 20.36 USD By Investing.com - Investing.com Australia

Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Orca adds $250M in financing to back launch of T cell therapy

In the clinic for Jan. 9, 2026

Other news to note for Jan. 9, 2026

Regulatory actions for Jan. 9, 2026

Money raised by biopharma

Biopharma money raised: Jan. 1-8, 2026

Illumina adds former NIH official as medical chief (ILMN:NASDAQ) - Seeking Alpha

Thermo Fisher Scientific to phase out Weaverville operations by end of 2026 - WLOS

Novartis to build fourth US radiotherapy factory in Florida

Insmed’s ‘ginormous’ lung drug sales; J&J’s US pricing deal

Venture firm a16z raises $700M; Ribo Life's $230M Hong Kong IPO